Where does Nextremity Solutions, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nextremity Solutions, Inc. ranks #9,332 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Nextremity Solutions, Inc. hold?

Nextremity Solutions, Inc. holds 34 US utility patents granted between 2015 and 2024, spanning 3 technology areas.

What is Nextremity Solutions, Inc.'s Innovation Score?

Nextremity Solutions, Inc. has an Innovation Score of 28.2 out of 100 (26th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Nextremity Solutions, Inc. focus on?

Nextremity Solutions, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 27 patents, ranking #686 of 7,127 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Nextremity Solutions, Inc.'s patent grant rate increasing or decreasing?

Nextremity Solutions, Inc.'s recent grant velocity is -38% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Nextremity Solutions, Inc.'s patents?

Nextremity Solutions, Inc.'s patents average 14.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Nextremity Solutions, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Nextremity Solutions, Inc.

USPTO PatentsView assignee record - 34 granted patents across 3 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nextremity ranks #9,332 of 49,997 tracked US assignees by granted-patent volume, with 34 patents across 3 technology areas.

#9,332
of 49,997 US assignees by volume: 26th percentile
by Innovation Score (28.2/100): 14.7
avg claims per patent: -38%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9332 · US Corporation #9,332 · 34 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 34 grants
UPPER-Q #9,332/49,997
PHOTO-FINISH Merrimack Pharmaceut…
CPC-NARROW A61B · 3 areas
INNOV-THIN 28.2/100
CLAIMS-RICH 14.7 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -38% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Merrimack Pharmaceuticals, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Nextremity’s 28.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.3 pts (44%) Velocity 1.0 pts (4%) Breadth 6.1 pts (22%) Claim depth 8.8 pts (31%)

Qualcomm Incorporated · highest

85
DNA · near

28
Honshu Chemical… · near

28
M Alphabet 3 · near

28
Nextremity Solutions · this assignee

28
Spring Meadow Nursery · near

28
3D Lighting… · lowest

7

What this shows Nextremity's Innovation Score is 28.2/100 (26th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Nextremity?

Each dot is one of Nextremity’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nextremity’s own 14.7 claims/patent is ABOVE the 11.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Nextremity vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Nextremity's grants concentrate

Nextremity Solutions, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 79.4% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2017 (8 grants) versus a trough of 1 in 2022. By volume, Nextremity sits between Merrimack Pharmaceuticals, Inc. and Nippon Steel & Sumikin Materials Co., Ltd..

Nextremity's three-year grant acceleration

Nextremity Solutions, Inc. shows 2 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Merrimack Pharmac…

34
Messer Industries…

34
National Universi…

34
Neofect

34
Nidec GPM

34
Nidec Seimitsu

34
Niigata University

34
Nippon Steel & Su…

34
Nextremity Soluti… ◀

34

What this shows Nextremity holds 34 patents at rank #9,330, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nextremity

By rank, the assignees closest to #9,330 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Nextremity's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Nextremity, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Nextremity ranks #686 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (28 here).

Honshu Chemical Industry Co., Ltd. 28 Spring Meadow Nursery Inc. 28 DNA Electronics, Inc. 28 M. Alphabet 3, LLC 28

Nextremity's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 26th percentile higher than 26% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Nextremity Solutions, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	20.6%
2016	3	8.8%
2017	8	23.5%
2019	3	8.8%
2020	7	20.6%
2021	4	11.8%
2022	1	2.9%
2024	1	2.9%

Which technologies does Nextremity Solutions, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 27

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 10

Y10T - Technical Subjects Covered BY Former US Classification 2

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Nextremity Solutions, Inc.'s patent record in context - here's where to go next.

Nextremity Solutions, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 79.4% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #9,332 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Nextremity Solutions, Inc. against Merrimack Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.